Which antibiotic wins? new study tests penicillin against standard care for staph blood infection

NCT ID NCT06726395

Recruiting now Disease control Sponsor: Region Skane Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether penicillin works better than the usual antibiotic cloxacillin for people with a Staph blood infection that is sensitive to penicillin. About 420 adults will be randomly assigned to one of the two treatments. The main goal is to see who survives 90 days without complications like relapse or side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS (S.) AUREUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial infectious disease with sepsis staphylococcal infection staphylococcus aureus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STAPHYLOCOCCAL BACTERAEMIA STAPHYLOCOCCUS (S.) AUREUS INFECTION STAPHYLOCOCCUS AUREUS BACTERAEMIA STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BSI; BACTEREMIA)

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Skånes universitetssjukhus, Region Skåne
RECRUITING

Lund, 22467, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact